November 2024, Cambridge, MA – Seasoned drug delivery executive, Steven Kaufman, to join Portal Instruments as their Chief Commercial Officer. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
November, 2024 Cambridge, MA – Portal Instruments is pleased to announce that Steven Kaufman will be joining Portal Instruments as their interim Chief Commercial Officer.
Steven is a recognized leader in the device industry, having held numerous leadership roles related to Business Development, Product Management, Marketing and Strategy. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
Patrick Anquetil, CEO, welcomed Steven, noting Steven's broad expertise in the area of self-injection devices and his proven track-record taking devices from design, development, manufacture, final assembly to clinical and then commercial launch in Europe, North America and APAC. "Steven's expertise in drug delivery will be a strong asset to Portal Instruments as we continue to move towards commercialization."
September 2021 - Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th. The keynote will be followed by a Q&A session.
September 2024 - Portal Instruments welcomes Matt Regan to its Board of Directors. Regan has held extensive leadership roles for prominent pharmaceutical companies such as Abbvie, Novo Nordisk and Micreos.
June 2021 - Needles are a 150-year-old technology. The world around us is rapidly evolving but drug delivery has not made the same technological strides that other medical devices have. Portal Instruments is looking to change that with a highly innovative needle-free drug delivery injector.
Please fill out the details below and we will get back to you shortly.